Disease Markers / 2019 / Article / Tab 1

Research Article

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population

Table 1

Clinical and demographic characteristics of MS patients and control subjects.

VariableMS ()CS ()

Demographics
 Age (years)135 (28-43)36 (28-44)
Gender2
 Male29 (58)30 (60)
 Female71 (142)70 (140)
Clinical characteristics
 Disease duration (years)18
Disease severity1
 EDSS1.9 (0.9-4.4)
 MSSS3.7 (1.1-6.5)
Clinical variant2
 RRMS94 (188)
 SPMS6 (12)
Therapy2
 Treatment naive11 (22)
 Glatiramer acetate51 (102)
 Beta interferons23 (46)
 Azathioprine3 (6)
 Biologicals (natalizumab and fingolimod)0.5 (1)
 Combined immunosuppressive therapy3 (6)

EDSS = expanded disability status scale; MSSS = multiple sclerosis severity score; RRMS = recurrent remittent multiple sclerosis; SPMS = secondary progressive multiple sclerosis. 1Data is shown in median (p25-p75). 2Data is shown in percentage.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.